Announcements
- Audited results for the year ended 31 Dec 2023
- Business Update for Q1 2024
- Notice of Results
- Unaudited Full Year Trading Update
- Appointment of new Chief Financial Officer
- Q3 2023 U.S. Commercial Highlights
- PDMR Transaction Notification
- Abstract to be presented at Healthcare Conference
- Chief Financial Officer Transition
- Result of REX Retail Offer
More ▼
Key statistics
On Thursday, Shield Therapeutics PLC (1JS:FRA) closed at 0.016, 68.42% above the 52 week low of 0.0095 set on Apr 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.016 |
---|---|
High | 0.016 |
Low | 0.016 |
Bid | -- |
Offer | -- |
Previous close | 0.016 |
Average volume | 7.00k |
---|---|
Shares outstanding | 782.06m |
Free float | 381.49m |
P/E (TTM) | -- |
Market cap | 14.47m GBP |
EPS (TTM) | -0.0458 GBP |
Data delayed at least 15 minutes, as of May 16 2024.
More ▼